Project Toxicologist

Regeneron is currently seeking a talented and motivated Project Toxicologist to join our preclinical development team, reporting to the Associate Director, Toxicology. This position is responsible for all aspects of preclinical toxicology related to the development of novel antibody therapeutics.

·                     Design, implement, and monitor outsourced toxicology studies

·                     Critically review toxicology data and provide input on safety assessments

·                     Prepare toxicology-related documents for internal reports and regulatory submissions.

·                     Participate in cross-functional development-team activities.

·                     Other responsibilities and duties as required

Regeneron is a fully integrated biopharmaceutical company that discovers, develops, manufacturers, and commercializes medicines for the treatment of serious medical conditions. In addition to ARCALYST (rilonacept) Injection for Subcutaneous Use, which is approved for the treatment of a rare inflammatory condition, Regeneron has completed Phase 3 clinical trials of rilonacept for a new indication and of product candidates EYLEA (aflibercept injection; VEGF Trap Eye) in diseases of the eye and ZALTRAP (aflibercept) (VEGF Trap) in colorectal cancer. EYLEA is currently under review with U.S. and European regulatory authorities. Additional therapeutic candidates developed from proprietary Regeneron technologies for creating fully human monoclonal antibodies are in earlier stage development programs in rheumatoid arthritis, pain, cholesterol reduction, allergic and immune conditions, and cancer.